In vitro activity of RBx 7644 (ranbezolid) on biofilm producing bacteria

International Journal of Antimicrobial Agents

Volumn 24, Issue 4, 2004, Pages 369-373

  Mathur, Tarun ^a   Bhateja, Pragya ^a   Pandya, Manisha ^a   Fatma, Tasneem ^b   Rattan, Ashok ^a  

^a RANBAXY RESEARCH LABORATORIES   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Biofilm; Device related infection; Glass adherent bacteria; Ranbezolid; Slime production

Indexed keywords

ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; RANBEZOLID; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; DEVICE INFECTION; DRUG ACTIVITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG POTENCY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; BACTERIAL ADHESION; BIOFILMS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; FURANS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 5644246336     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.04.012     Document Type: Article

References (22)

1. Maki DG, Infections due to infusion therapy. In: Bennett JV, Brachman PS, editors. Hospital infections. Boston: Little Brown & Co.; 1992.
2. Raad I., Darouiche R., Hachem R. Antibiotics and prevention of microbial colonization of catheters. Antimicrob. Agents Chemother. 39:1995;741-746
3. Widmer A.F., Frei R., Rajacic Z. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J. Infect. Dis. 162:1990;96-102
4. Widmer A.F., Wiestener A., Frei R. Killing of non-growing and adherent Escherichia coli determines drug efficacy in device related infections. Antimicrob. Agents Chemother. 35:1991;741-746
5. Zimmerli W., Frei R., Widmer A.F., Rajacic Z. Microbiological test to predict treatment outcome in experimental device related infection due to Staphylococcus aureus. J. Antimicrob. Chemother. 33:1994;959-967
6. Hoellman D.B., Lin G., Ednie L.M., Rattan A., Jacobs M.R., Appelbaum P.C. Antipneumococcal and antistaphylococcal activities of ranbezolid (RBx 7644), a new oxazolidinone, compared to those of other agents. Antimicrob. Agents Chemother. 47:2003;1148-1150
7. Ednie L.M., Rattan A., Jacobs M.R., Appelbaum P.C. Antianaerobe activity of RBx 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents. Antimicrob. Agents Chemother. 47:2003;1143-1147
8. Blake J.E., Metcalfe M.A. A shared noncapsular antigen is responsible for false positive reactions by Staphylococcus epidermidis in commercial agglutination test for Staphylococcus aureus. J. Clin. Microbiol. 39:2001;544-550
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard. NCCLS Publication no. M7-A5. Pennsylvania, Wayne: National committee for Clinical Laboratory Standards; 2000.
10. Polonio R.E., Mermel L.A., Paquette G.E., Sperry J.F. Eradication of biofilm-forming Staphylococcus epidermidis (RP 62A) by a combination of sodium salicylate and vancomycin. Antimicrob. Agents Chemother. 45:2001;3262-3266
11. Raad I. Intravascular-catheter-related infections. Lancet. 351:1998;893-898
12. Maki D.G., Weise C.E., Sarafin H.W. A semiquantitative culture method for identifying intravenous-catheter-related infections. New Engl. J. Med. 296:1977;1305-1309
13. Mandell G.L. The antimicrobial activity of rifampin: emphasis on the relation to phagocytes. Rev. Infect. Dis. 5(Suppl 5):1983;S463-S467
14. Minuth J.N., Holmes T.M., Musher D.M. Activity of tetracycline, doxycycline and minocycline against methicillin susceptible and resistant staphylococci. Antimicrob. Agents Chemother. 6:1974;411-414
15. Norwood S., Ruby A., Civetta J., Cortes V. Catheter related infections and associated septicemia. Chest. 99:1991;968-975
16. Raad I, Darouiche, R. Central venous catheters (CVC) coated with minocycline and rifampin (M/R) for the prevention of catheter- related bacteremia (CRB). In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract J7. USA, Washington, DC: American Society for Microbiology; 1995. p. 258.
17. Evans D.J., Allison D.G., Brown M.R.W., Gilbert P. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. J. Antimicrob. Chemother. 27:1991;177-184
18. Roberts A.P., Pratten J., Wilson M., Mullany P. Transfer of a conjugative transposon, Tn 5397, in a model of oral biofilm. FEMS Microbiol. Lett. 177:1999;63-66
19. Donlan R.M. Biofilms and device associated infections. Emerg. Infect. Dis. 7:2001;277-281
20. Drago L., Vecchi E.De., Valli M., Nicola L., Gismondo M.R. Effect of linezolid in comparison with that of vancomycin on glycocalix production: in vitro study. Antimicrob. Agents Chemother. 46:2002;598-599
21. Tsidorias S., Gold H.S., Sakoulas G., Eliopoulos G.M., Wennersten C., Venkataraman L. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet. 358:2001;207-208
22. Carsenti-Etesse H., Durant J., Entenza J., et al. Effects of sub inhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci tissue culture plates. Antimicrob. Agents Chemother. 37:1993;921-923